ACAN - Tissue Dissociator

AMENDMENT TO RESPONSE DEADLINE CLOSING TIME: Please disregard the Ariba Discovery posting response deadline closing time. All required supporting documentation and statement of capabilities must be submitted by 08 May 2024 at 14:00 EDT. All statement of capabilities submitted after 14:00 EDT will result in the statement of capability being declared non-responsive. Health Canada requires a Tissue Dissociator to conduct regulatory research on vaccines against pathogens such as influenza, respiratory syncytial virus, Lyme disease and SARS-CoV-2. Any interested supplier must demonstrate by way of a statement of capabilities that its product/equipment/system (as appropriate) meets the specifications listed in the ACAN document. Contract duration The estimated contract period will be 13 month(s), with a proposed start date of 2024/05/20. Trade agreements Canadian Free Trade Agreement (CFTA) Contracting organization Organization Department of Public Works and Government Services (PSPC) Address 11 Laurier St, Phase III, Place du Portage Gatineau, Quebec, K1A 0S5 Canada Contracting authority Gonzalez2, Adriana (SPAC/PSPC) Email adriana.gonzalez2@tpsgc-pwgsc.gc.ca Buying organization(s) Organization Department of Health (HC) Address Address Locator 0900C2 Ottawa, Ontario, K1A0K9